维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="DERDEMEZIS CS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Ef- fects of plant sterols and stanols beyond low density lipoprotein cholesterol lowering 显示文摘	Derdemezis CS Filippatos TD Mikhailidis DP	2010	Cardiovasc Pharmacol Ther2010，，3：	1
2	Increased plasma visfatin levels in sujects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
3	Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Kiortsis DN	2007	J Endocrinol Invest2007，30，4：	1
4	Increased plasma Visfatin levels in subjects with the metabolic syndrome 显示文摘	FILIPPATOS TD DERDEMEZIS CS GAZII F	2008	Eur J Clin Invest2008，38，1：	1
5	Excess body we-ight and risk of first-ever acute ischaemic non-embolic stroke in eld-erly subjects显示文摘	Milionis HJ Filippatos TD Derdemezis CS	2007	Eur J Neurol2007，14，7：	1
6	Increased plasma visfatin levels in subjects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
7	Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile 显示文摘	FILIPPATOS TD TSIMIHODIMOS V DERDEMEZIS CS etal	2013	Nutr Metab Cardiovasc Dis2013，23，4：	1
8	Orlistat- associated adverse effects and drug interactions: a critical review 显示文摘	FILIPPATOS TD DERDEMEZIS CS GAZI IF	2008	DrugSaf2008，31，1：	1
9	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia显示文摘	Kostapanos MS Derdemezis CS Filippatos TD	2008	Eur J Pharmacol2008，578，23：	1
10	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia 显示文摘	Kostapanos MS Derdemezis CS Filippatos TD	2008	Eur J Pharmacol2008，578，23：	1
11	Visfatin/PBEF and atherosclerosis-related diseases 显示文摘	Filippatos TD Randeva HS Derdemezis CS	2010	Curr Vasc Pharmacol2010，8，1：	1
12	Orlistatassociated adverse effects and drug interactions显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Drug Saf2008，31，1：	1
13	Increased plasma Visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS GaziIF		0，，01：	1
14	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia显示文摘	Kostapanos MS Derdemezis CS Filippatos TD		0，，2：	1
15	Effect of rosuvastatin treament on plasma Visfatin levels in patients with primary hyperlipidemia显示文摘	Kostapanos MS Derdemezis CS Filippatos TD		0，，02：	1
16	Effect of rosuvastatin treatment on plasma visfatin levels in patientswith p rimary hyperlip idemia显示文摘	KostapanosMS Derdemezis CS Filippatos TD	2008	Eur J Pharmacol2008，578，223：	1
17	Increased plasma vis- fatin levels in subjects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
18	Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Kiortsis DN	2007	J Endoerinol Invest2007，30，4：	1
19	Increased plasma visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
20	Increased plasma levels of vifatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Kiortsis DN	2007	J Endocrinol Invest2007，30，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示